others

Multi-omics longitudinal analyses in stages I to III CRC patients: Surveillance liquid biopsy test to predict early recurrence and enable risk-stratified postoperative CRC management.

Background: One-third of colorectal cancer (CRC) recurs following curative surgery and chemotherapy. Accordingly, novel methods are needed to predict recurrence to enable clinical course mitigating strategies. Serial monitoring of plasma by mass …

A metabolism-related radiomics signature for predicting the prognosis of colorectal cancer

Background: Radiomics refers to the extraction of a large amount of image information from medical images, which can provide decision support for clinicians. In this study, we developed and validated a radiomics-based nomogram to predict the …

Identification, development and validation of a circulating miRNA-based diagnostic signature for early detection of gastric cancer

A cancer pharmacogenomic screen powering crowd-sourced advancement of drug combination prediction

## Abstract The effectiveness of most cancer targeted therapies is short-lived. Tumors often develop resistance that might be overcome with drug combinations. However, the number of possible combinations is vast, necessitating data-driven approaches …

Gene expression signature in surgical tissues and endoscopic biopsies identifies high-risk T1 colorectal cancers

Genome-wide discovery and identification of a novel miRNA signature for recurrence prediction in stage II and III colorectal cancer

## Abstract Purpose: The current tumor–node–metastasis (TNM) staging system is inadequate at identifying patients with high-risk colorectal cancer. Using a systematic and comprehensive biomarker discovery and validation approach, we …

A Novel Non-Invasive Circulating Mirna Signature for Detection of Esophageal Adenocarcinoma

A microRNA signature associated with metastasis of T1 colorectal cancers to lymph nodes

Genome-Wide Analysis Revealed a Robust Gene Expression Signature to Identify Lymph Node Metastasis in Submucosal Colorectal Cancer